Zeitschrift für Bioäquivalenz und Bioverfügbarkeit

Abstrakt

Biologics and Biosimilars - A Review on their Therapeutics Activities

Chetan Suthar*

Biologics medicine has a great advance in the treatment of serious illness. The manufacturing of these molecules which are large and complex is quite difficult because they are been made in the living cells grown in the laboratory. The replica of biologic medicine is impossible for the manufacturer to manufacture due to some of the factors such as the inherent complexity of the biologics and the proprietary details of the manufacturing process for the original biological medicine often can be referred to as the reference products. Due to this, the copies of the biological products produced are called as biosimilar, the biosimilar is highly similar to biological products but not identical.